Alessio Branchini

Via Fossato Di Mortara 74
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A.

Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A.

Journal: Molecular medicine (Cambridge, Mass.)

Published: April 14, 2026

Rational design of a novel engineered factor X with chimeric activation peptide as bypassing agent for hemophilia.

Rational design of a novel engineered factor X with chimeric activation peptide as bypassing agent for hemophilia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 16, 2025

"An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B": reply.

"An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B": reply.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 05, 2025

Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.

Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.

Journal: IUBMB life

Published: March 31, 2025

Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based Innovations.

Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based Innovations.

Journal: IUBMB life

Published: March 31, 2025

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis.

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis.

Journal: Thrombosis research

Published: February 28, 2025

Engineered tRNAs efficiently suppress CDKL5 premature termination codons.

Engineered tRNAs efficiently suppress CDKL5 premature termination codons.

Journal: Scientific reports

Published: May 22, 2024

Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties.

Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties.

Journal: Nature communications

Published: March 16, 2024

An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B.

An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 07, 2024

1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects.

1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects.

Journal: International journal of molecular sciences

Published: February 02, 2023

Translation termination codons in protein synthesis and disease.

Translation termination codons in protein synthesis and disease.

Journal: Advances in protein chemistry and structural biology

Published: September 10, 2022

Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors.

Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 11, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026